Brief: Novabay Pharmaceuticals Expands Its Eyecare Product Portfolio
10/01/2022 11:51
Jan 10 (Reuters) - NovaBay Pharmaceuticals Inc NBY.A :
* NOVABAY PHARMACEUTICALS EXPANDS ITS EYECARE PRODUCT PORTFOLIO WITH THE
LAUNCH OF
LUBRICATING EYE DROPS FOR THE IMMEDIATE RELIEF OF DRY EYE SYMPTOMS
Source text for Eikon: ID:nBw65HCDha
Further company coverage: NBY.A
Recent news on Stablecoin Development
See all newsBrief: Stablecoin Development Corporation Reports First Quarter 2026 Financial Results
Brief: Tether Says Participated In A $134 Million Financing Round For Stablecoin Development Corporation
Brief: Novabay Pharmaceuticals Announces Name Change To Stablecoin Development Corporation
Brief: Novabay Pharmaceuticals Says David Lazar Resigns As CEO
Brief: NovaBay Pharmaceuticals Files For Mixed Shelf Of Up To $200 Million - SEC Filing